Saturday 17 October 2026
Export ACTU’s income statement to Excel — free account
Actuate Therapeutics, Inc.
ACTU Healthcare Biotechnology
In the quarter to June 2026, EPS grew 33.3% and free cash flow fell 5.54%, each against the same quarter a year earlier.
0.61
0.11
+22.00%
Follow ACTU
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Current Ratio |
+8 more quarters Free account |
2.74 | 2.39 | 1.80 | 1.25 |
Net Debt/EBITDA |
3.09 | 2.81 | 1.43 | 0.90 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.23 | 0.82 | 0.89 | 0.91 | |
Interest Coverage |
(1,073.02) | (919.31) | (1,118.82) | (962.08) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.31) | (0.18) | (0.21) | (0.18) | |
Cash per Share |
0.79 | 0.63 | 0.35 | 0.19 | |
Shareholders Equity per Share |
0.51 | 0.38 | 0.16 | 0.04 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.51 | 0.38 | 0.16 | 0.04 | |
Free Cash Flow |
(6.68) | (3.74) | (5.02) | (4.41) | |
Working Capital |
11.07 | 7.94 | 3.80 | 0.94 | |
Net Current Asset Value |
10.67 | 7.53 | 3.39 | 0.54 | |
| Other line items | |||||
Quick Ratio |
2.66 | 2.31 | 1.72 | 1.16 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.31) | (0.18) | (0.21) | (0.18) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Payables |
1.79 | 1.72 | 1.92 | 2.12 | |
Average Assets |
15.99 | 11.68 | 6.70 | 6.08 | |
Average Common Equity |
8.15 | 4.01 | (0.65) | (0.83) |
Columns are period end dates